Florian Vogl
Chief Tech/Sci/R&D Officer en IMMUTEP LIMITED .
Perfil
Florian D.
Vogl is currently the Chief Medical Officer at Immutep Ltd.
He previously worked as the Head of Clinical Development Europe at Rainier Therapeutics, Inc. and as the Chief Medical Officer at Cellestia Biotech AG.
Dr. Vogl obtained a doctorate degree from Ludwig-Maximilians-Universität München.
Cargos activos de Florian Vogl
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUTEP LIMITED | Chief Tech/Sci/R&D Officer | 01/05/2023 |
Antiguos cargos conocidos de Florian Vogl.
| Empresas | Cargo | Fin |
|---|---|---|
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Corporate Officer/Principal | - |
Cellestia Biotech AG
 Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Chief Tech/Sci/R&D Officer | - |
Formación de Florian Vogl.
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| IMMUTEP LIMITED | Health Technology |
| Empresas privadas | 2 |
|---|---|
Rainier Therapeutics, Inc.
Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Health Technology |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Florian Vogl
